Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1
- PMID: 8332187
- DOI: 10.1038/364308a0
Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1
Abstract
In higher eukaryotes, the Ras and Raf-1 proto-oncoproteins transduce growth and differentiation signals initiated by tyrosine kinases. The Ras polypeptide and the amino-terminal regulatory domain of Raf-1 (residues 1-257) are shown to interact, directly in vitro and in a yeast expression system. Raf-1 (1-257) binds GTP-Ras in preference to GDP-Ras, and inhibits Ras-GAP activity. Mutations in and around the Ras effector domain impair Ras binding to Raf-1 (1-257) and Ras transforming activity in parallel.
Similar articles
-
Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro.Nature. 1993 Jul 22;364(6435):352-5. doi: 10.1038/364352a0. Nature. 1993. PMID: 8332195
-
Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane.Nature. 1994 Jun 2;369(6479):411-4. doi: 10.1038/369411a0. Nature. 1994. PMID: 8196769
-
Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets.Oncogene. 1995 Aug 3;11(3):447-54. Oncogene. 1995. PMID: 7630628
-
Interactions between Ras and Raf: key regulatory proteins in cellular transformation.Mol Reprod Dev. 1995 Dec;42(4):493-9. doi: 10.1002/mrd.1080420418. Mol Reprod Dev. 1995. PMID: 8607981 Review.
-
Ras regulatory interactions: novel targets for anti-cancer intervention?Bioessays. 1994 Mar;16(3):187-91. doi: 10.1002/bies.950160309. Bioessays. 1994. PMID: 8166672 Review.
Cited by
-
Photonanozyme-Kras-ribosome combination treatment of non-small cell lung cancer after COVID-19.Front Immunol. 2024 Sep 6;15:1420463. doi: 10.3389/fimmu.2024.1420463. eCollection 2024. Front Immunol. 2024. PMID: 39308869 Free PMC article. Review.
-
Functional and structural insights into RAS effector proteins.Mol Cell. 2024 Aug 8;84(15):2807-2821. doi: 10.1016/j.molcel.2024.06.027. Epub 2024 Jul 17. Mol Cell. 2024. PMID: 39025071 Review.
-
Driver Mutations in Pancreatic Cancer and Opportunities for Targeted Therapy.Cancers (Basel). 2024 May 9;16(10):1808. doi: 10.3390/cancers16101808. Cancers (Basel). 2024. PMID: 38791887 Free PMC article. Review.
-
KRAS4b:RAF-1 Homogenous Time-Resolved Fluorescence Resonance Energy Transfer Assay for Drug Discovery.Methods Mol Biol. 2024;2797:159-175. doi: 10.1007/978-1-0716-3822-4_12. Methods Mol Biol. 2024. PMID: 38570459
-
Mutations in the Serine/Threonine Kinase BRAF: Oncogenic Drivers in Solid Tumors.Cancers (Basel). 2024 Mar 20;16(6):1215. doi: 10.3390/cancers16061215. Cancers (Basel). 2024. PMID: 38539548 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
